18 The V-antigen, a virulence-associated protein, was first identified in Yersinia pestis more 19 than half a century ago. Since then, other V-antigen homologs and orthologs have been 20 discovered and are now considered vital molecules for the toxic effects mediated by the 21 type III secretion system in infections caused by various pathogenic Gram-negative 22 bacteria. After purifying recombinant V-antigen proteins including PcrV from 23 Pseudomonas aeruginosa, LcrV from Yersinia, LssV from Photorhabdus luminescens, 24 AcrV from Aeromonas salmonicida, and VcrV from Vibrio parahaemolyticus, we 25 developed an enzyme-linked immunoabsorbent assay to measure titers against each V-26 antigen in the sera collected from 186 adult volunteers. Different titer-specific correlation 27 levels were determined for the five V-antigens. The anti-LcrV and anti-AcrV titers shared 28 the highest correlation with each other, with a correlation coefficient of 0.84. The next 29 highest correlation coefficient was between anti-AcrV and anti-VcrV titers at 0.79, while 30 the lowest correlation was found between anti-LcrV and anti-VcrV titers, which were still 31 higher than 0.7 Sera from mice immunized with one of the five recombinant V-antigens 32 displayed cross-antigenicity with some of the other four V-antigens, supporting the 33 results from the human sera. Thus, the serum anti-V-antigen titer measurement system 3 34 could potentially be used for epidemiological investigations on various pathogenic Gram-35 negative bacteria. 4 36 Introduction 37
7 89 endotoxin-free Gram-negative bacteria V-antigens were prepared as reported previously 90 ( Fig. 1) [17, 20] . 
